{"id":"https://openalex.org/W2409454359","doi":null,"title":"[Treatment of hypertension in patients with left ventricular hypertrophy].","display_name":"[Treatment of hypertension in patients with left ventricular hypertrophy].","alternate_titles":[],"publication_year":2004,"publication_date":"2004-03-18","ids":{"openalex":"https://openalex.org/W2409454359","mag":"2409454359","pmid":"https://pubmed.ncbi.nlm.nih.gov/15039810"},"language":"no","primary_location":{"id":"pmid:15039810","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15039810","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2409454359"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038806566","display_name":"Per Omvik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Per Omvik","raw_affiliation_strings":["LIFE-studiegruppen. per.omvik@med.uib.no","LIFE-studiegruppen"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"LIFE-studiegruppen. per.omvik@med.uib.no","institution_ids":[]},{"raw_affiliation_string":"LIFE-studiegruppen","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110411961","display_name":"Bj\u00f8rn Bratland","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bj\u00f8rn Bratland","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060239510","display_name":"Gerhard Gerhardsen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Gerhard Gerhardsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039210250","display_name":"Kjell Gisholt","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kjell Gisholt","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030780368","display_name":"Terje Risanger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Terje Risanger","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032747750","display_name":"T. Smedsrud","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Tore Smedsrud","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5087577272","display_name":"Sverre Erik Kjeldsen","orcid":"https://orcid.org/0000-0003-2389-0272","observed_orcids":["https://orcid.org/0000-0003-2389-0272"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sverre E Kjeldsen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"124","issue":"6","first_page":"788","last_page":"791"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12075","display_name":"Sodium Intake and Health","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10924","display_name":"Cardiovascular Health and Disease Prevention","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.7070000171661377},{"id":"https://openalex.org/keywords/left-ventricular-hypertrophy","display_name":"left ventricular hypertrophy","score":0.9990000128746033},{"id":"https://openalex.org/keywords/losartan","display_name":"losartan","score":0.9779999852180481},{"id":"https://openalex.org/keywords/atenolol","display_name":"atenolol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/life-studies","display_name":"life studies","score":0.7210000157356262},{"id":"https://openalex.org/keywords/cardiovascular-mortality","display_name":"cardiovascular mortality","score":0.6460000276565552},{"id":"https://openalex.org/keywords/stroke-prevention","display_name":"stroke prevention","score":0.8159999847412109},{"id":"https://openalex.org/keywords/isolated-systolic-hypertension","display_name":"isolated systolic hypertension","score":0.8999999761581421},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8920000195503235},{"id":"https://openalex.org/keywords/hydrochlorothiazide","display_name":"hydrochlorothiazide","score":0.8339999914169312},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6589999794960022}],"concepts":[{"id":"https://openalex.org/C2776525901","wikidata":"https://www.wikidata.org/wiki/Q411325","display_name":"Atenolol","level":3,"score":0.9527078866958618},{"id":"https://openalex.org/C2780288358","wikidata":"https://www.wikidata.org/wiki/Q410074","display_name":"Losartan","level":4,"score":0.9513579607009888},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8740769624710083},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.7841200828552246},{"id":"https://openalex.org/C2776002628","wikidata":"https://www.wikidata.org/wiki/Q1628627","display_name":"Left ventricular hypertrophy","level":3,"score":0.7696002721786499},{"id":"https://openalex.org/C2780361556","wikidata":"https://www.wikidata.org/wiki/Q423930","display_name":"Hydrochlorothiazide","level":3,"score":0.7258786559104919},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7145035266876221},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.636385977268219},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.6260389089584351},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5236596465110779},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.4926527142524719},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.35767292976379395},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.30324798822402954},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D001262","descriptor_name":"Atenolol","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017379","descriptor_name":"Hypertrophy, Left Ventricular","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D019808","descriptor_name":"Losartan","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:15039810","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15039810","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke","raw_type":"Clinical Trial"},{"id":"mag:2409454359","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/15039810","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2193111068","https://openalex.org/W2130136596","https://openalex.org/W4250934844","https://openalex.org/W2142567874","https://openalex.org/W2124211797","https://openalex.org/W2100231254","https://openalex.org/W2040308781","https://openalex.org/W2411950850","https://openalex.org/W2004792013","https://openalex.org/W2049566119"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,21,43],"LIFE":[2],"study":[3,22,44],"(Losartan":[4],"Intervention":[5],"For":[6],"Endpoint":[7],"reduction":[8,96,184],"in":[9,48,73,97,118,147,166,185,197],"hypertension)":[10],"is":[11],"a":[12],"randomized,":[13],"double-blind":[14],"comparison":[15],"of":[16,55,71],"losartan":[17,26,62,86,120],"and":[18,31,65,87,108,123,156,188,201],"atenolol-based":[19],"treatment.":[20],"hypothesis":[23],"was":[24,61,81,111,140,159],"that":[25],"would":[27],"reduce":[28],"cardiovascular":[29,138,177],"morbidity":[30],"mortality":[32,139,158],"more":[33,176],"than":[34,179],"traditional":[35],"antihypertensive":[36],"treatment":[37],"with":[38,149,168,199],"atenolol.":[39,92],"MATERIAL":[40],"AND":[41],"METHODS:":[42],"included":[45],"9193":[46],"patients":[47,72,148,167,198],"seven":[49],"countries.":[50],"RESULTS:":[51],"By":[52],"the":[53,56,58,94,100,119,182],"end":[54],"study,":[57],"mean":[59],"dose":[60],"82":[63],"mg":[64],"atenonol":[66],"79":[67],"mg,":[68],"whereas":[69],"94%":[70],"both":[74],"groups":[75],"received":[76],"additional":[77,191],"hydrochlorothiazide.":[78],"Blood":[79],"pressure":[80,187,195],"reduced":[82,112,127,141,160],"30/17":[83],"mmHg":[84],"by":[85,91,113,128,142,161],"29/17":[88],"mm":[89],"Hg":[90],"Despite":[93],"same":[95,183],"blood":[98,186,194],"pressure,":[99],"primary":[101],"combined":[102],"endpoint":[103],"(cardiovascular":[104],"mortality,":[105],"non-fatal":[106],"stroke":[107],"myocardial":[109],"infarction)":[110],"13.0%":[114],"(p":[115,130,144,163],"=":[116,131,145,154,164,171],"0.021)":[117],"group.":[121],"Non-fatal":[122],"fatal":[124],"strokes":[125],"were":[126],"24.9%":[129],"0.001).":[132],"In":[133],"two":[134],"pre-specified":[135],"subgroup":[136],"analyses,":[137],"46%":[143],"0.01)":[146],"isolated":[150],"systolic":[151],"hypertension":[152,200],"(n":[153,170],"1326),":[155],"total":[157],"39%":[162],"0.002)":[165],"diabetes":[169],"1159).":[172],"INTERPRETATION:":[173],"Losartan":[174],"prevented":[175],"complications":[178],"atenolol":[180],"for":[181],"have":[189],"positive":[190],"effects":[192],"beyond":[193],"control":[196],"left":[202],"ventricular":[203],"hypertrophy.":[204]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2409454359","counts_by_year":[{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-15T12:55:33.944570","created_date":"2016-06-24T00:00:00"}
